CLINICAL_TRIALS
trial_result
· 2021-10-25
Clinical Trial Update: Evaluation of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease [Phase 2]
Summary
Phase 2 clinical trial evaluating OC-01 Nasal Spray for signs and symptoms of Dry Eye Disease has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oyster Point Pharma, Inc. | Conditions: Dry Eye Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-10-25